Cantin AM - Search Results

1

The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients.

Morin C, Cantin AM, Vézina FA, Fortin S. Morin C, et al. Among authors: cantin am. Mar Drugs. 2018 May 26;16(6):184. doi: 10.3390/md16060184. Mar Drugs. 2018. PMID: 29861448 Free PMC article. Clinical Trial.

2

Potential for antioxidant therapy of cystic fibrosis.

Cantin AM. Cantin AM. Curr Opin Pulm Med. 2004 Nov;10(6):531-6. doi: 10.1097/01.mcp.0000138997.29276.a1. Curr Opin Pulm Med. 2004. PMID: 15510062 Review.

3

Prolastin aerosol therapy and sputum taurine in cystic fibrosis.

Cantin AM, Berthiaume Y, Cloutier D, Martel M. Cantin AM, et al. Clin Invest Med. 2006 Aug;29(4):201-7. Clin Invest Med. 2006. PMID: 16986483

4

Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma.

Morin C, Fortin S, Cantin AM, Rousseau E. Morin C, et al. Among authors: cantin am. Am J Respir Cell Mol Biol. 2011 Aug;45(2):366-75. doi: 10.1165/rcmb.2010-0156OC. Epub 2010 Nov 5. Am J Respir Cell Mol Biol. 2011. PMID: 21057106

5

Plasma biomarkers and cystic fibrosis lung disease.

Cantin AM, Bilodeau G, Larivée P, Richter MV. Cantin AM, et al. Clin Invest Med. 2012 Jul 4;35(4):E173-81. doi: 10.25011/cim.v35i4.17145. Clin Invest Med. 2012. PMID: 22863555 Clinical Trial.

6

Anti-cancer effects of a new docosahexaenoic acid monoacylglyceride in lung adenocarcinoma.

Morin C, Fortin S, Cantin AM, Sirois M, Sirois C, Rizcallah E, Rousseau É. Morin C, et al. Among authors: cantin am. Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):319-34. doi: 10.2174/1574891x113089990032. Recent Pat Anticancer Drug Discov. 2013. PMID: 23092161

7

Proresolving Action of Docosahexaenoic Acid Monoglyceride in Lung Inflammatory Models Related to Cystic Fibrosis.

Morin C, Cantin AM, Rousseau É, Sirois M, Sirois C, Rizcallah E, Fortin S. Morin C, et al. Among authors: cantin am. Am J Respir Cell Mol Biol. 2015 Oct;53(4):574-83. doi: 10.1165/rcmb.2014-0223OC. Am J Respir Cell Mol Biol. 2015. PMID: 25781052

8

Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.

Cantin AM, Hartl D, Konstan MW, Chmiel JF. Cantin AM, et al. J Cyst Fibros. 2015 Jul;14(4):419-30. doi: 10.1016/j.jcf.2015.03.003. Epub 2015 Mar 23. J Cyst Fibros. 2015. PMID: 25814049 Free article. Review.

9

Antioxidants and Chronic Obstructive Pulmonary Disease.

Vézina FA, Cantin AM. Vézina FA, et al. Among authors: cantin am. Chronic Obstr Pulm Dis. 2018 Oct 8;5(4):277-288. doi: 10.15326/jcopdf.5.4.2018.0133. Chronic Obstr Pulm Dis. 2018. PMID: 30723785 Free PMC article.

10

Leukocyte elastase inhibition therapy in cystic fibrosis: role of glycosylation on the distribution of alpha-1-proteinase inhibitor in blood versus lung.

Cantin AM, Woods DE, Cloutier D, Héroux J, Dufour EK, Leduc R. Cantin AM, et al. J Aerosol Med. 2002 Summer;15(2):141-8. doi: 10.1089/089426802320282266. J Aerosol Med. 2002. PMID: 12184864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page